Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Sickle Cell Disease: Managing Pain
source: National heart, lung and blood institute
year: 2018
summary/abstract:Currently, sickle cell disease has no widely available cure. However, if you have the disease, certain treatments can help with your pain.
Good health care is important for people who have sickle cell disease, so see your doctor regularly. Work with your doctor to create a pain control plan that makes sense for you, and carry it with you if you go to the emergency room.
· Mild pain is often treated at home. More severe pain may need to be treated in a clinic or hospital.
· Fluids can help prevent dehydration, which can worsen pain.
· Over-the-counter pain medicine can help with mild to moderate pain.
· Stronger medicines called opioids may be prescribed for more severe pain.
· Ask your doctor about a medicine called hydroxyurea that may decrease pain episodes. Some patients may benefit from taking a new medicine called L-glutamine oral powder. Talk to your doctor to determine if this medicine is right for you.
· Other methods for managing pain include getting physical therapy, using a heating pad, or engaging in activities, such as listening to music, that help distract you from the pain.
read more
+myBinderRelated Content
-
A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)Limited evidence guides opioid dosing st...
-
Acute Vaso-Occlusive Episode in Sickle Cell AnemiaAcute Vaso-Occlusive Episode in Sickle C...
-
Virtual Reality Helps Reduce Pain Among Patients With Sickle Cell DiseaseImmersive virtual reality appeared effec...
-
CTX001 Continues to Show Promise in Severe SCDA single dose of CTX001, an experimental...
-
A multiple drug approach to preventing sickle cell crisisSickle cell disease is characterized by ...
-
When Cracking Down On Opioids Means Tougher Access For Sickle Cell PatientsMany people with sickle cell disease wil...
-
Orphan Drug Designation Granted for CSL Behring’s Investigational Plasma-Derived Hemopexin Therapy for Sickle ...Global biotherapeutics leader CSL Behrin...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.